Quantcast
Don't Miss

Novavax loss, revenue increase

Novavax Inc., of Gaithersburg, a biopharmaceutical company creating vaccines for infectious diseases worldwide, reported an increase in both revenue and net loss for the second quarter. Novavax had a net loss of $17.9 million, or 8 cents per share, for the second quarter of 2014, compared with a net loss of $12.6 million, or 8 cents per share, for the second quarter of 2013. Revenue increased 134 percent to $8.3 million, as compared with $3.5 million for the same period in 2013. Government contracts revenue — from trials of flu vaccines — in the second quarter of 2014 increased 213 percent to $5.1 million from $1.6 million in 2013.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 
Scroll To Top